在学龄前儿童中,饮食模式和患喘的风险
Rodney R Mudau1, Kuku K Voyi2, Joyce J Shirinde3
1University of Pretoria, Department of Human Nutrition, Room 4-6, Level 4 HW Snyman South, Private Bag X323, RSA, School of Health Systems and Public Health, Faculty of Health Sciences, South Africa.
Clinical nutrition ESPEN
|July 25, 2024
概括
健康的饮食可以保护学龄前儿童免受喘. 相反,高含糖饮料或混合食品的饮食会增加喘的风险. 这些发现表明,饮食修改可能有助于预防儿童喘.
科学领域:
- 儿科过敏和免疫学
- 营养流行病学 营养流行病学
- 公共卫生 营养 公共卫生 营养
背景情况:
- 儿童早期的饮食是喘发展的潜在因素.
- 了解饮食模式对于喘预防策略至关重要.
- 这项研究调查了学龄前儿童饮食习惯与喘之间的联系.
研究的目的:
- 确定在学龄前儿童的饮食模式和喘之间的关联.
- 为了确定与喘风险增加或减少相关的特定饮食模式.
- 为了告知儿童喘潜在的饮食干预措施.
主要方法:
- 在189名学龄前儿童 (1-8岁) 中进行了无与伦比的病例对照研究.
- 从定量食品频率问卷 (QFFQ) 数据使用主要成分分析 (PCA) 识别的饮食模式.
- 多变量逻辑回归分析了饮食模式和喘之间的关系.
主要成果:
- 确定了四种主要的饮食模式:肉类/料,健康,含糖/含糖饮料和混合饮料.
- 含糖/含糖饮料 (aOR 7.0) 和混合饮食模式 (aOR 4.0) 与更高的喘概率有关.
- 一种健康的饮食模式 (aOR 0.02) 与喘可能性有负面关联.
结论:
- 健康的饮食模式与学龄前儿童患喘的可能性较低有关.
- 饮食修改提出了一个潜在的干预策略,以解决儿童喘率上升的问题.
- 促进健康的饮食习惯可能有助于预防儿童喘.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
380
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
380
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264


